Zolbetuximab or Immunotherapy as the Initial Targeted Therapy in CLDN18.2-Positive, HER2-Negative Advanced Gastric Cancer: Weighing the Options. - Easaw, Jacob C.; Lim, Howard J.; Karachiwala, Hatim; Gill, Sharlene; Zhu, Xiaofu; Bateman, Justin (Current Oncology, 2025)